Next Article in Journal
Effect of Cu and Cs in the β-Mo2C System for CO2 Hydrogenation to Methanol
Next Article in Special Issue
Baeyer-Villiger-Including Domino Two-Step Oxidations of β-O-Substituted Primary Alcohols: Reflection of the Migratory Aptitudes of O-Substituted Alkyl Group in the Outcome of the Reaction
Previous Article in Journal
Improved NOx Reduction Using C3H8 and H2 with Ag/Al2O3 Catalysts Promoted with Pt and WOx
Previous Article in Special Issue
Catalytic Foldamers: When the Structure Guides the Function
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Double Spirocyclization of Arylidene-Δ2-Pyrrolin-4-Ones with 3-Isothiocyanato Oxindoles

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Submission received: 25 September 2020 / Revised: 13 October 2020 / Accepted: 14 October 2020 / Published: 19 October 2020
(This article belongs to the Special Issue Organocatalysis: Advances, Opportunity, and Challenges)

Abstract

:
Arylidene-Δ2-pyrrolin-4-ones undergo organocatalyzed double spirocyclization with 3-isothiocianato oxindoles in a domino 1,4/1,2-addition sequence. The products contain three contiguous stereocenters (ee up to 98%, dr up to 99:1, 12 examples). The absolute configuration of the major diastereomer was determined by single crystal X-ray analysis. Along with heterocyclic Michael acceptors based on oxazolone, isoxazolone, thiazolidinone, pyrazolone, and pyrimidinedione, the reported results display the applicability of unsaturated Δ2-pyrrolin-4-ones (pyrrolones) for the organocatalyzed construction of 3D-rich pyrrolone-containing heterocycles.

Graphical Abstract

1. Introduction

Spirooxindoles, containing various spiro rings attached at the C-3 position of the oxindole framework, represent a privileged core scaffold frequently encountered in natural and synthetic products exhibiting many different biological activities [1,2,3,4], as shown in Figure 1 [5,6,7,8,9]. Conformational rigidity of spirooxindoles provides an excellent strategy to enforce the desired conformation for a specific and strong ligand-protein binding [10].
Development of new catalytic methods for stereoselective construction of diverse spirooxindole frameworks, possessing both a variable pharmacophore and functional groups that enable follow-up transformations (i.e., the generation of compound libraries for the evaluation of their biological activities), represents an important ongoing challenge. In this context, organocatalysis has emerged as a powerful synthetic tool for the preparation of complex molecular architectures from simple starting materials, especially due to its operational simplicity, easily available catalysts, and benign reaction conditions [11,12,13,14,15,16,17,18,19,20,21]. 3-Isothiocyanato oxindoles, possessing both the nucleophilic and the electrophilic reaction site, represent a convenient building block for the cascade construction of diverse heterocyclic systems [22,23,24,25]. These transformations can be conducted under mild organocatalytic conditions in a highly stereoselective manner. Thus, various mono- and bis-spiroheterocycles and their fused analogues have been constructed featuring thioimidazolidinone-spirooxindoles [26,27,28,29,30], fused-thioimidazolidinone-spirooxindoles [31], thiopyrrolidinone-spirooxindoles [32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52], fused-thiopyrrolidinone-spirooxindoles [53,54,55,56], thiooxazolidinone-spirooxindoles [57,58,59], and thio-1,2,4-triazolidinone [60].
For the construction of bis-spiroheterocyclic thiopyrrolidinone-spirooxindoles with 3-isothiocyanato oxindoles, arylidene or (functionalized) alkylidene (hetero)cyclic Michael acceptors have been applied. Thereof, bicyclic systems are prevalent (i.e., indole, tetralone, and indanone-derived Michael acceptors) [33,35,37,38,40,41,46,47,52]. Among monocyclic heterocycles, Michael acceptors based on oxazolone [49], isoxazolone [45], thiazolidinone [36], pyrazolone [45,51], and pyrimidinedione (barbituric acid) [39] have been applied, with no reports on the application of pyrrolone-derived 1,4-acceptors (Scheme 1). The pyrrolone (Δ2-pyrrolin-4-one) core is an interesting motif prominent in several natural products (Brevianamide A [61]), bioactive molecules (modulators of opioid receptors [62], antimalarials [63,64], HIV-1 protease inhibitors [65]), and phytopharmaceuticals (herbicides [66]).
In continuation of our research on the implementation of pyrrolone derivatives in asymmetric organocatalyzed transformations [67,68,69,70], we herein report a successful application of the arylidene-Δ2-pyrrolin-4-ones [71] 1 for the enantioselective construction of oxindole-thiopyrolidinone-Δ2-pyrrolin-4-one bis-spiroheterocycles 3 (Scheme 1).

2. Results and Discussion

The DABCO-catalyzed reaction between methyl (E)-5-benzylidene-1,2-dimethyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylate (1a) and 3-isothiocyanato-1-methylindolin-2-one (2a) in THF yielded the corresponding racemic oxindole-thiopyrrolidineone-Δ2-pyrrolin-4-one rac-3a. The subsequent screening of the chiral noncovalent bifunctional organocatalysts I-VII based on camphor, cyclohexane-1,2-diamine, and quinuclidine in toluene at 25 °C is presented in Scheme 2. Several cyclohexane-1,2-diamine- and quinuclidine-based catalysts (VIb, VIIIb, IXb, Xb, XIb) containing either the thiourea or the squaramide H-bond donor and 3,5-bis(trifluoromethyl)phenyl group are compatible with the model reaction 1a + 2a3a in both yields and stereoselectivity. Among the screened catalysts, the best results along with the cleanest reaction profile were obtained with the catalyst IXb (dr = 95:5, ee = 79%, 60% yield).
With the optimal catalyst IXb in hand, solvent optimization for the reaction 1a + 2a3a was performed (Table 1). Compared to toluene (Entry 1, 79% ee), the enantioselectivity decreased significantly in dichloromethane, acetonitrile, and methanol (Entries 6, 10, 11; up to 52% ee), while in ethereal solvents (Entries 2, 5, 9) and acetone (Entry 8), the enantioselectivity improved (82–87% ee). A drop of diastereoselectivity was observed in diethyl ether, acetonitrile, and methanol (Entries 3, 10, 11). In terms of yield, the conversion was lower in the majority of the tested solvents (Entries 2–6, 8–11). Trifluorotoluene (Entry 7) gave the cleanest reaction profile with practically unchanged diastereoselectivity, alongside the highest yield and enantioselectivity (dr = 93:7, ee = 87%, 67% yield).
Having established the optimal reaction conditions (catalyst IXb, trifluorotoluene), the scope of the studied transformation was evaluated. For that purpose, several Δ2-pyrrolin-4-ones 1 [71,72] and two 3-isothiocyanato oxindoles 2 [30,53,59] were applied (Figure 2). The results of the investigated scope are presented in Scheme 3. With the N-methyl-substituted Δ2-pyrrolin-4-ones 1ag, the effect of electron-donating and electron-withdrawing substituents on the phenyl ring of the arylidene moiety, including tiophen-2-yl moiety, did not establish a clear trend; the products were isolated with good to excellent enantioselectivities (80–98% ee), diastereoselectivity above 75:25, and low to moderate yields (18–67%). Despite our best efforts, stereoisomers of the products rac-3mp, derived from pyrrolones 1hk and unsubstituted 3-isothiocyanato oxindole 2a, could not be separated on chiral HPLC columns (see the Supplementary Materials). The products 3fj, derived from 5-methyl substituted 3-isothiocyanato oxindole 2b, compared with the products 3ae, derived from unsubstituted 3-isothiocyanato oxindole 2a, were generally formed in slightly higher enantioselectivities though lower yields at longer reaction times.
The absolute configuration (3R,3′S,4′R) of the major stereoisomer of the product 3b was determined by single crystal X-ray analysis (Figure 3) (see the Supplementary Materials). Consequently, the same absolute configuration (3R,3′S,4′R) was assigned to all the major diastereomers of products 3aj. The reaction of 3-isothiocyanato oxindoles 2a and 2b with N-unsubstituted pyrrolones 1l and 1m yielded the corresponding products 3k and 3l in low yields (7 and 14%), and low to moderate enantioselectivities (21 and 57% ee), respectively. Based on previous observations, where enantiomeric products were obtained in the reaction of (E)- and (Z)-pyrrolones 1 with 2-mercaptoacetaldehyde [71], an enantiomeric relationship of (3S,3′R,4′S) was tentatively assigned to products 3k and 3l (Scheme 3).
The follow-up methylation of compound 3a with iodomethane in the presence of K2CO3 in acetone gave the S-methylated product 4 (Scheme 4).
According to the Grayson [72,73] proposal of stereochemistry origin in squaramide-catalyzed asymmetric Michael addition reactions and the observed absolute configuration revealed by X-ray analysis of the major diastereomer of compound 3b (cf. Figure 3), a plausible transition state (TS) leading to the product (as exemplified for the formation of product 3a) can be postulated (Scheme 5). The protonated catalyst activates and coordinates the pyrrolone electrophile via the protonated quinuclidine moiety, while the squaramide functionality simultaneously orients and activates the nucleophile for the attack. The Si face of the nucleophile attacks the Re face of the electrophile, which is followed by the spiro-cyclisation yielding product 3a (Scheme 5).

3. Materials and Methods

3.1. Materials and Methods, Syntheses, and Characterization

Solvents for chromatography and extractions were of technical grade. They were distilled prior to use. Technical grade anhydrous Na2SO4 was used for drying of extracts. Melting points were determined on a Kofler micro hot stage and an SRS OptiMelt MPA100-Automated Melting Point System (Stanford Research Systems, Sunnyvale, CA, USA). The NMR spectra were obtained on a Bruker UltraShield 500 plus (Bruker, Billerica, MA, USA) at 500 MHz for 1H and 126 MHz for a 13C nucleus, using DMSO-d6 and CDCl3 with TMS as the internal standard, as solvents. Mass spectra were recorded on an Agilent 6224 Accurate Mass TOF LC/MS (Agilent Technologies, Santa Clara, CA, USA), and IR spectra on a Perkin-Elmer Spectrum BX FTIR spectrophotometer (PerkinElmer, Waltham, MA, USA). Column chromatography (CC) was performed on silica gel (Silica gel 60, particle size: 0.035–0.070 mm (Sigma-Aldrich, St. Louis, MO, USA)). HPLC analyses were performed on an Agilent 1260 Infinity LC (Agilent Technologies, Santa Clara, CA, USA) using CHIRALPAK IA-3 (0.46 cm ø × 25 cm), CHIRALPAK AD-H (0.46 cm ø × 250 mm), CHIRALCEL AS-H (0.46 cm ø × 250 mm), and CHIRALCEL OD-H (0.46 cm ø × 250 mm) as chiral columns (CHIRAL TECHNOLOGIES, INC., West Chester, PA, USA). All the commercially available chemicals used were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Methyl 5-arylidene-2-methyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylates 1 [71] and 3-isothiocyanatooxindoles 2a and 2b [30,53,59] were prepared following the literature procedures.
Organocatalysts Ia [70], II [69], IIIa [70], IV [70], Vb [74], VIa [75], VIb [76], VIIa [77], VIIb [76], IXa [78], IXb [79], IXc [80], Xb [81], XIa [19], and XIb [78] were prepared following the literature procedures; organocatalysts VIIIb and XII were purchased from Sigma-Aldrich.

3.2. Synthesis of (E)-Methyl 5-Arylidene-1,2-Dimethyl-4-oxo-4,5-Dihydro-1H-Pyrrole-3-Carboxylate-General Procedure 1 (GP1)

To a solution of methyl (Z)-2-(2-chloroacetyl)-3-(methylamino)but-2-enoate (E) [71] (1 equivalent) in anhydrous EtOH at room temperature, KOH (1.05 equivalent, ω = 0.85) was added and the resulting reaction mixture was heated to 75 °C. After the disappearance of the starting material (ca. 45 min), according to the TLC analysis (mobile phase: EtOAc/MeOH = 4:1) (Figure S1), the mixture was cooled to room temperature. KHSO4 (0.5 equivalent) was added, followed by the addition of H2O (5 mL), and the mixture was stirred for 10 min at room temperature, followed by the addition of an aldehyde (1 equivalent). The mixture was heated to 75 °C and stirred until the disappearance of the Δ2-pyrrolin-4-one intermediate A (ca. 30 min), according to the TLC analysis (mobile phase: EtOAc/MeOH = 4:1) (Figure S1). Afterwards, the solution was cooled to room temperature, followed by the slow addition of ice-cold water (ca. 100 mL) until the formation of the precipitate. The precipitate was collected by filtration, washed with ice-cold water, and dried under a high vacuum at 60 °C. Unless noted otherwise, the crude product was purified by recrystallization from MeOH/H2O and dried under a high vacuum at 60 °C, which afforded the product 1 (compounds 1c, 1f, 1g, 1i) as a brightly colored solid. Other 5-arylidene-2-methyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylates were prepared following the literature procedures [71].

3.3. Organocatalyzed Bis-Spiroheterocyclization-Preparation of Racemic Mixtures-General Procedure 2 (GP2)

To a mixture of arylidene-Δ2-pyrrolin-4-one 1 (0.1 mmol), 3-isothiocyanato oxindole 2 (0.13 mmol), and 1,4-diazabicyclo[2.2.2]octane (DABCO) (0.01 mmol, 1.12 mg) under argon, anhydrous THF (1 mL) was added and the resulting reaction mixture was stirred at 25 °C for 24 h. Volatile components were evaporated in vacuo and the residue was purified by column chromatography (Silica gel 60, mobile phase: EtOAc/petroleum ether = 2:1). Fractions containing the pure racemic product rac-3 were combined and volatile components were evaporated in vacuo followed by HPLC analysis on chiral columns. Products rac-3 (compounds rac-3k-n), that could not be separated on chiral columns, were fully characterized.

3.4. Organocatalyzed Stereoselective Bis-Spiroheterocyclization-General Procedure 3 (GP3)

To a mixture, arylidene-Δ2-pyrrolin-4-one 1 (0.1 mmol), 3-isothiocyanato oxindole 2 (0.13 mmol), and organocatalyst I-XII (10 mol%) under argon, anhydrous solvent (1 mL) was added and the resulting reaction mixture was stirred at 25 °C for 24–72 h.
(i) For catalyst and solvent screening (model reaction 1a + 2a3a), volatile components were evaporated in vacuo and the residue was purified by flash column chromatography to remove the catalyst (Silica gel 60, mobile phase: EtOAc/petroleum ether = 2:1). Fractions containing the product 3a were combined and volatile components were evaporated in vacuo followed by determination of the enantiomeric excess and diastereomeric ratio by HPLC analysis.
(ii) For the reaction scope synthesis (reactions 1 + 23; compounds 3al), volatile components were evaporated in vacuo and the residue was purified by column chromatography (Silica gel 60, mobile phase: EtOAc/petroleum ether = 2:1). Fractions containing pure product 3 were combined and volatile components were evaporated in vacuo, followed by determination of the enantiomeric excess by HPLC analysis, determination of the diastereomeric ratio by 1H-NMR, and full characterization.

4. Conclusions

We have shown that Michael acceptors based on Δ2-pyrrolin-4-ones (pyrrolones), which are easily prepared from bulk chemicals [71], undergo stereoselective organocatalyzed double spiro-cyclization with 3-isothiocianato oxindoles. A library of 12 products containing three contiguous stereocenters (ee up to 98%, dr up to 99:1) has been synthesized and a follow-up transformation demonstrated. This research offers a new entry for the construction of 3D-rich pyrrolone-containing heterocycles.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2073-4344/10/10/1211/s1, Synthesis and Characterization Data for Compounds 1 and 3; HPLC data; Copies of 1H- and 13C-NMR spectra; Structure Determination by NMR-NOESY spectra (for compounds 1); Copies of HRMS reports of Compounds 1 and 3; Structure Determination by X-ray Diffraction Analysis, Figure S6: Ortep drawing of compound 3b.

Author Contributions

For Conceptualization, U.G., S.R., J.S., F.P., and B.Š.; methodology, U.G. and S.R.; software, U.G., S.R., L.C., J.S., F.P., and B.Š.; validation, U.G., S.R., J.S., F.P., and B.Š.; formal analysis, U.G., Ž.T., H.B., and S.R.; investigation, S.R., Ž.T., L.C., and U.G.; resources, U.G., S.R. and J.S.; data curation, U.G., Ž.T., L.C., J.S., S.R., F.P., H.B., and B.Š.; writing—original draft preparation, U.G., S.R., J.S., F.P., and B.Š.; writing—review and editing, U.G., J.S., S.R., L.C., F.P., and B.Š.; visualization, U.G., B.Š., and J.S.; supervision, U.G.; project administration, U.G. and J.S.; funding acquisition, J.S., U.G., F.P., and B.Š. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Slovenian Research Agency through grants P1-0179 and P1-0175.

Acknowledgments

We thank EN-FIST Centre of Excellence, Trg Osvobodilne fronte 13, 1000 Ljubljana, Slovenia, for using BX FTIR spectrophotometer and Agilent 1260 Infinity HPLC system.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Panda, S.S.; Mohapatra, P.P.; Jones, R.A.; Bachawala, P. Spirooxindoles as Potential Pharmacophores. Mini Rev. Med. Chem. 2017, 17, 1515–1536. [Google Scholar] [CrossRef] [PubMed]
  2. Yu, B.; Yu, D.-Q.; Liu, H.-M. Spirooxindoles: Promising scaffolds for anticancer agents. Eur. J. Med. Chem. 2015, 97, 673–698. [Google Scholar] [CrossRef] [PubMed]
  3. Zheng, Y.; Tice, C.M.; Singh, S.B. The use of spirocyclic scaffolds in drug discovery. Bioorg. Med. Chem. Lett. 2014, 24, 3673–3682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Galliford, C.V.; Scheidt, K.A. Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. Angew. Chem. Int. Ed. 2007, 46, 8748–8758. [Google Scholar] [CrossRef]
  5. Zhao, Y.; Yu, S.; Sun, W.; Liu, L.; Lu, J.; McEachern, D.; Shargary, S.; Bernard, D.; Li, X.; Zhao, T.; et al. A Potent Small-Molecule Inhibitor of the MDM2-p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice. J. Med. Chem. 2013, 56, 5553–5561. [Google Scholar] [CrossRef] [PubMed]
  6. Crosignani, S.; Page, P.; Missotten, M.; Colovray, V.; Cleva, C.; Arrighi, J.-F.; Atherall, J.; Macritchie, J.; Martin, T.; Humbert, Y.; et al. Discovery of a New Class of Potent, Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases. J. Med. Chem. 2008, 51, 2227–2243. [Google Scholar] [CrossRef] [PubMed]
  7. Edmondson, S.; Danishefsky, S.J.; Sepp-Lorenzino, L.; Rosen, N. Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogs. J. Am. Chem. Soc. 1999, 121, 2147–2155. [Google Scholar] [CrossRef]
  8. Yeung, B.K.S.; Zou, B.; Rottmann, M.; Lakshminarayana, S.B.; Ang, S.H.; Leong, S.Y.; Tan, J.; Wong, J.; Keller-Maerki, S.; Fischli, C.; et al. Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria. J. Med. Chem. 2010, 53, 5155–5164. [Google Scholar] [CrossRef]
  9. Yu, Q.; Guo, P.; Jian, J.; Chen, Y.; Xu, J. Nine-step total synthesis of (-)-strychnofoline. Chem. Commun. 2018, 54, 1125–1128. [Google Scholar] [CrossRef]
  10. Ye, N.; Chen, H.; Wold, E.A.; Shi, P.-Y.; Zhou, J. Therapeutic Potential of Spirooxindoles as Antiviral Agents. ACS Infect. Dis. 2016, 2, 382–392. [Google Scholar] [CrossRef]
  11. Torres, R.R. (Ed.) Stereoselective Organocatalysis: Bond Formation Methodologies and Activation Modes, 1st ed.; JohnWiley & Sons: Hoboken, NJ, USA, 2013. [Google Scholar]
  12. Jakab, G.; Schreiner, P.R. Brønsted Acids: Chiral (Thio)urea Derivatives. In Comprehensive Enantioselective Organocatalysis: Catalysts, Reactions, and Applications, 1st ed.; Dalko, P.I., Ed.; Wiley-VCH: Weinheim, Germany, 2013; pp. 315–342. [Google Scholar]
  13. Krištofíková, D.; Modrocká, V.; Mečiarová, M.; Šebesta, R. Green Asymmetric Organocatalysis. ChemSusChem 2020, 13, 2828–2858. [Google Scholar] [CrossRef]
  14. Chanda, T.; Zhao, J.C.G. Recent Progress in Organocatalytic Asymmetric Domino Transformations. Adv. Synth. Catal. 2018, 360, 2–79. [Google Scholar] [CrossRef]
  15. Held, F.E.; Tsogoeva, S.B. Asymmetric cycloaddition reactions catalyzed by bifunctional thiourea and squaramide organocatalysts: Recent advances. Catal. Sci. Technol. 2016, 6, 645–667. [Google Scholar] [CrossRef] [Green Version]
  16. Holland, M.C.; Gilmour, R. Deconstructing Covalent Organocatalysis. Angew. Chem. Int. Ed. 2015, 54, 3862–3871. [Google Scholar] [CrossRef] [PubMed]
  17. Chauhan, P.; Mahajan, S.; Kaya, U.; Hack, D.; Enders, D. Bifunctional Amine-Squaramides: Powerful Hydrogen-Bonding Organocatalysts for Asymmetric Domino/Cascade Reactions. Adv. Synth. Catal. 2015, 357, 253–281. [Google Scholar] [CrossRef]
  18. Serdyuk, O.V.; Heckel, C.M.; Tsogoeva, S.B. Bifunctional primary amine-thioureas in asymmetric organocatalysis. Org. Biomol. Chem. 2013, 11, 7051–7071. [Google Scholar] [CrossRef] [Green Version]
  19. Malerich, J.P.; Hagihara, K.; Rawal, V.H. Chiral Squaramide Derivatives are Excellent Hydrogen Bond Donor Catalysts. J. Am. Chem. Soc. 2008, 130, 14416–14417. [Google Scholar] [CrossRef] [Green Version]
  20. Alemán, J.; Parra, A.; Jiang, H.; Jørgensen, K.A. Squaramides: Bridging from Molecular Recognition to Bifunctional Organocatalysis. Chem. Eur. J. 2011, 17, 6890–6899. [Google Scholar] [CrossRef]
  21. Enders, D.; Huttl, M.R.M.; Grondal, C.; Raabe, G. Control of four stereocentres in a triple cascade organocatalytic reaction. Nature 2006, 441, 861–863. [Google Scholar] [CrossRef]
  22. Tan, F.; Cheng, H.-G. Recent advances in catalytic asymmetric cascade reactions of 3-isothiocyanato oxindoles for synthesis of spirooxindoles. Targets Heterocycl. Syst. 2017, 21, 158–180. [Google Scholar]
  23. Mei, G.-J.; Shi, F. Catalytic asymmetric synthesis of spirooxindoles: Recent developments. Chem. Commun. 2018, 54, 6607–6621. [Google Scholar] [CrossRef]
  24. Gasperi, T.; Miceli, M.; Campagne, J.-M.; Marcia de Figueiredo, R. Non-covalent organocatalyzed domino reactions involving oxindoles: Recent advances. Molecules 2017, 22, 1636. [Google Scholar] [CrossRef] [PubMed]
  25. Cheng, D.; Ishihara, Y.; Tan, B.; Barbas, C.F. Organocatalytic Asymmetric Assembly Reactions: Synthesis of Spirooxindoles via Organocascade Strategies. ACS Catal. 2014, 4, 743–762. [Google Scholar] [CrossRef]
  26. Zhang, C.-B.; Dou, P.-H.; You, Y.; Wang, Z.-H.; Zhou, M.-Q.; Xu, X.-Y.; Yuan, W.-C. Organocatalytic asymmetric [3+2]-cycloaddition of 3-isothiocyanato oxindoles with 1,3,5-trisubstituted-hexahydro-1,3,5-triazines to access spiro-imidazolidinethione-oxindoles. Tetrahedron 2019, 75, 130571. [Google Scholar] [CrossRef]
  27. Gui, H.-Z.; Wei, Y.; Shi, M. Construction of spirothioureas having an amino quaternary stereogenic center via a [3+2] annulation of 3-isothiocyanato oxindoles with 2-aminoacrylates. Org. Biomol. Chem. 2018, 16, 9218–9222. [Google Scholar] [CrossRef]
  28. Du, D.; Xu, Q.; Li, X.-G.; Shi, M. Construction of Spirocyclic Oxindoles through Regio- and Stereoselective [3+2] or [3+2]/[4+2] Cascade Reaction of α,β-Unsaturated Imines with 3-Isothiocyanato Oxindole. Chem. Eur. J. 2016, 22, 4733–4737. [Google Scholar] [CrossRef] [PubMed]
  29. Bai, M.; Cui, B.-D.; Zuo, J.; Zhao, J.-Q.; You, Y.; Chen, Y.-Z.; Xu, X.-Y.; Zhang, X.-M.; Yuan, W.-C. Quinine-catalyzed asymmetric domino Mannich-cyclization reactions of 3-isothiocyanato oxindoles with imines for the synthesis of spirocyclic oxindoles. Tetrahedron 2015, 71, 949–955. [Google Scholar] [CrossRef]
  30. Cai, H.; Zhou, Y.; Zhang, D.; Xu, J.; Liu, H. A Mannich/cyclization cascade process for the asymmetric synthesis of spirocyclic thioimidazolidineoxindoles. Chem. Commun. 2014, 50, 14771–14774. [Google Scholar] [CrossRef]
  31. Zhang, C.-B.; Dou, P.-H.; Zhao, J.-Q.; Yuan, W.-C. Organocatalyzed asymmetric cascade Mannich/cyclization of 3-isothiocyanato oxindoles with cyclic ketimines for the synthesis of polycyclic spiro-thioimidazolidine-oxindoles. Tetrahedron 2020, 76, 131116. [Google Scholar] [CrossRef]
  32. Zhao, B.-L.; Du, D.-M. Asymmetric Synthesis of Spirooxindoles with Seven Stereocenters via Organocatalyzed One-pot Three-component Sequential Cascade Reactions. Adv. Synth. Catal. 2019, 361, 3412–3419. [Google Scholar] [CrossRef]
  33. Chen, S.; Wang, G.-L.; Xu, S.-W.; Tian, M.-Y.; Zhang, M.; Liu, X.-L.; Yuan, W.-C. Regio- and stereoselective [3+2] cycloaddition reaction: Access to isoxazole-dispirobisoxindoles featuring three contiguous stereocenters. Org. Biomol. Chem. 2019, 17, 6551–6556. [Google Scholar] [CrossRef] [PubMed]
  34. Bai, M.; Chen, Y.-Z.; Cui, B.-D.; Xu, X.-Y.; Yuan, W.-C. Thiourea-catalyzed asymmetric domino Michael-cyclization reaction of 3-isothiocyanato oxindoles with β,γ-unsaturated α-keto esters for the synthesis of spirocyclic oxindoles. Tetrahedron 2019, 75, 2155–2161. [Google Scholar] [CrossRef]
  35. Zhu, W.-R.; Chen, Q.; Lin, N.; Chen, K.-B.; Zhang, Z.-W.; Fang, G.; Weng, J.; Lu, G. Organocatalytic Michael/cyclization cascade reactions of 3-isothiocyanato oxindoles with 3-trifluoroethylidene oxindoles: An approach for the synthesis of 3′-trifluoromethyl substituted 3,2′-pyrrolidine-bispirooxindoles. Org. Chem. Front. 2018, 5, 1375–1380. [Google Scholar] [CrossRef]
  36. Song, Y.-X.; Du, D.-M. Squaramide-Catalyzed Asymmetric Michael/Cyclization Cascade Reaction of Unsaturated Thiazolidinones and 3-Isothiocyanato Oxindoles: Synthesis of New Bispirocyclic Heterocycles. Synthesis 2018, 50, 1535–1545. [Google Scholar]
  37. Lin, N.; Long, X.-w.; Chen, Q.; Zhu, W.-r.; Wang, B.-c.; Chen, K.-b.; Jiang, C.-w.; Weng, J.; Lu, G. Highly efficient construction of chiral dispirocyclic oxindole/thiobutyrolactam/chromanone complexes through Michael/cyclization cascade reactions with a rosin-based squaramide catalyst. Tetrahedron 2018, 74, 3734–3741. [Google Scholar] [CrossRef]
  38. Lin, Y.; Liu, L.; Du, D.-M. Squaramide-catalyzed asymmetric Michael/cyclization cascade reaction of 3-isothiocyanato oxindoles with chalcones for synthesis of pyrrolidinyl spirooxindoles. Org. Chem. Front. 2017, 4, 1229–1238. [Google Scholar] [CrossRef]
  39. Zhao, H.-W.; Tian, T.; Pang, H.-L.; Li, B.; Chen, X.-Q.; Yang, Z.; Meng, W.; Song, X.-Q.; Zhao, Y.-D.; Liu, Y.-Y. Organocatalytic [3+2] Cycloadditions of Barbiturate-Based Olefins with 3-Isothiocyanato Oxindoles: Highly Diastereoselective and Enantioselective Synthesis of Dispirobarbiturates. Adv. Synth. Catal. 2016, 358, 2619–2630. [Google Scholar] [CrossRef]
  40. Wu, C.; Jing, L.; Qin, D.; Yin, M.; He, Q. Organocatalytic asymmetric synthesis of trans-configured trispirooxindoles through a cascade Michael-cyclization reaction. Tetrahedron Lett. 2016, 57, 2857–2860. [Google Scholar] [CrossRef]
  41. Kayal, S.; Mukherjee, S. Catalytic enantioselective cascade Michael/cyclization reaction of 3-isothiocyanato oxindoles with exocyclic α,β-unsaturated ketones en route to 3,2′-pyrrolidinyl bispirooxindoles. Org. Biomol. Chem. 2016, 14, 10175–10179. [Google Scholar] [CrossRef]
  42. Chowdhury, R.; Kumar, M.; Ghosh, S.K. Organocatalyzed enantioselective Michael addition/cyclization cascade reaction of 3-isothiocyanato oxindoles with arylidene malonates. Org. Biomol. Chem. 2016, 14, 11250–11260. [Google Scholar] [CrossRef]
  43. Du, D.; Jiang, Y.; Xu, Q.; Tang, X.-Y.; Shi, M. Enantioselective [3+2]-Cyclization of 3-Isothiocyanato Oxindoles with Trifluoromethylated 2-Butenedioic Acid Diesters. ChemCatChem 2015, 7, 1366–1371. [Google Scholar] [CrossRef]
  44. Kayal, S.; Mukherjee, S. Catalytic Asymmetric Michael Addition/Cyclization Cascade Reaction of 3-Isothiocyanatooxindoles with Nitro Olefins. Eur. J. Org. Chem. 2014, 2014, 6696–6700. [Google Scholar] [CrossRef]
  45. Cui, B.-D.; Li, S.-W.; Zuo, J.; Wu, Z.-J.; Zhang, X.-M.; Yuan, W.-C. Quinine-catalyzed asymmetric domino Michael-cyclization reaction for the synthesis of spirocyclic oxindoles bearing two spiro quaternary centers and three consecutive stereocenters. Tetrahedron 2014, 70, 1895–1902. [Google Scholar] [CrossRef]
  46. Wu, H.; Zhang, L.-L.; Tian, Z.-Q.; Huang, Y.-D.; Wang, Y.-M. Highly Efficient Enantioselective Construction of Bispirooxindoles Containing Three Stereocenters through an Organocatalytic Cascade Michael-Cyclization Reaction. Chem. Eur. J. 2013, 19, 1747–1753. [Google Scholar] [CrossRef]
  47. Tan, F.; Cheng, H.-G.; Feng, B.; Zou, Y.-Q.; Duan, S.-W.; Chen, J.-R.; Xiao, W.-J. Highly Enantioselective Organocatalytic Michael Addition/Cyclization Cascade Reaction of Ylideneoxindoles with Isothiocyanato Oxindoles: A Formal [3+2] Cycloaddition Approach to Optically Active Bispirooxindole Derivatives. Eur. J. Org. Chem. 2013, 2013, 2071–2075. [Google Scholar] [CrossRef]
  48. Liu, X.-L.; Han, W.-Y.; Zhang, X.-M.; Yuan, W.-C. Highly Efficient and Stereocontrolled Construction of 3,3′-Pyrrolidonyl Spirooxindoles via Organocatalytic Domino Michael/Cyclization Reaction. Org. Lett. 2013, 15, 1246–1249. [Google Scholar] [CrossRef] [PubMed]
  49. Han, W.-Y.; Li, S.-W.; Wu, Z.-J.; Zhang, X.-M.; Yuan, W.-C. 3-Isothiocyanato oxindoles serving as powerful and versatile precursors to structurally diverse dispirocyclic thiopyrrolidineoxindoles through a cascade Michael/cyclization process with amino-thiocarbamate catalysts. Chem. Eur. J. 2013, 19, 5551–5556. [Google Scholar] [CrossRef]
  50. Du, D.; Jiang, Y.; Xu, Q.; Shi, M. Enantioselective Construction of Spirooxindole Derivatives: Asymmetric [3+2] Cyclization of Isothiocyanatooxindoles with Allenic Esters or 2-Butynedioic Acid Diesters. Adv. Synth. Catal. 2013, 355, 2249–2256. [Google Scholar] [CrossRef]
  51. Chen, Q.; Liang, J.; Wang, S.; Wang, D.; Wang, R. An asymmetric approach toward chiral multicyclic spirooxindoles from isothiocyanato oxindoles and unsaturated pyrazolones by a chiral tertiary amine thiourea catalyst. Chem. Commun. 2013, 49, 1657–1659. [Google Scholar] [CrossRef]
  52. Cao, Y.-M.; Shen, F.-F.; Zhang, F.-T.; Wang, R. Catalytic asymmetric Michael addition/cyclization of isothiocyanato oxindoles: Highly efficient and versatile approach for the synthesis of 3,2′-pyrrolidinyl mono- and bi-spirooxindole frameworks. Chem. Eur. J. 2013, 19, 1184–1188. [Google Scholar] [CrossRef]
  53. Zhang, L.-L.; Da, B.-C.; Xiang, S.-H.; Zhu, S.; Yuan, Z.-Y.; Guo, Z.; Tan, B. Organocatalytic double arylation of 3-isothiocyanato oxindoles: Stereocontrolled synthesis of complex spirooxindoles. Tetrahedron 2019, 75, 1689–1696. [Google Scholar] [CrossRef]
  54. Liu, L.; Zhao, B.-L.; Du, D.-M. Organocatalytic Asymmetric Michael/Cyclization Cascade Reaction of 3-Isothiocyanato Oxindoles with Maleimides for the Efficient Construction of Pyrrolidonyl Spirooxindoles. Eur. J. Org. Chem. 2016, 2016, 4711–4718. [Google Scholar] [CrossRef]
  55. Zhao, J.-Q.; Zhou, M.-Q.; Wu, Z.-J.; Wang, Z.-H.; Yue, D.-F.; Xu, X.-Y.; Zhang, X.-M.; Yuan, W.-C. Asymmetric Michael/Cyclization Cascade Reaction of 3-Isothiocyanato Oxindoles and 3-Nitroindoles with Amino-Thiocarbamate Catalysts: Enantioselective Synthesis of Polycyclic Spirooxindoles. Org. Lett. 2015, 17, 2238–2241. [Google Scholar] [CrossRef]
  56. Fu, Z.-K.; Pan, J.-Y.; Xu, D.-C.; Xie, J.-W. Organocatalytic domino Michael/cyclization reaction: Efficient synthesis of multi-functionalized tetracyclic spirooxindoles with multiple stereocenters. RSC Adv. 2014, 4, 51548–51557. [Google Scholar] [CrossRef]
  57. Kayal, S.; Mukherjee, S. Catalytic Aldol-Cyclization Cascade of 3-Isothiocyanato Oxindoles with α-Ketophosphonates for the Enantioselective Synthesis of β-Amino-α-hydroxyphosphonates. Org. Lett. 2015, 17, 5508–5511. [Google Scholar] [CrossRef]
  58. Chen, W.-B.; Han, W.-Y.; Han, Y.-Y.; Zhang, X.-M.; Yuan, W.-C. Highly efficient synthesis of spiro[oxazolidine-2-thione-oxindoles] with 3-isothiocyanato oxindoles and aldehydes via an organocatalytic cascade aldol-cyclization reaction. Tetrahedron 2013, 69, 5281–5286. [Google Scholar] [CrossRef]
  59. Chen, W.-B.; Wu, Z.-J.; Hu, J.; Cun, L.-F.; Zhang, X.-M.; Yuan, W.-C. Organocatalytic direct asymmetric aldol reactions of 3-isothiocyanato oxindoles to ketones: Stereocontrolled synthesis of spirooxindoles bearing highly congested contiguous tetrasubstituted stereocenters. Org. Lett. 2011, 13, 2472–2475. [Google Scholar] [CrossRef]
  60. Jiang, Y.; Pei, C.-K.; Du, D.; Li, X.-G.; He, Y.-N.; Xu, Q.; Shi, M. Enantioselective Synthesis of Spirooxindoles: Asymmetric [3+2] Cycloaddition of (3-Isothiocyanato)oxindoles with Azo Dicarboxylates. Eur. J. Org. Chem. 2013, 2013, 7895–7901. [Google Scholar] [CrossRef]
  61. Williams, R.M.; Kwast, E.; Coffman, H.; Glinka, T. Remarkable, enantio-divergent biogenesis of brevianamide A and B. J. Am. Chem. Soc. 1989, 111, 3064–3065. [Google Scholar] [CrossRef]
  62. Bowen, C.; Malcolm, S.; Melnick, L.; Xie, L. Modulators of Opioid Receptors and Methods of Use Thereof. WO 2013070659 A1, 16 May 2013. [Google Scholar]
  63. Murugesan, D.; Mital, A.; Kaiser, M.; Shackleford, D.M.; Morizzi, J.; Katneni, K.; Campbell, M.; Hudson, A.; Charman, S.A.; Yeates, C.; et al. Discovery and Structure-Activity Relationships of Pyrrolone Antimalarials. J. Med. Chem. 2013, 56, 2975–2990. [Google Scholar] [CrossRef]
  64. Murugesan, D.; Kaiser, M.; White, K.L.; Norval, S.; Riley, J.; Wyatt, P.G.; Charman, S.A.; Read, K.D.; Yeates, C.; Gilbert, I.H. Structure-Activity Relationship Studies of Pyrrolone Antimalarial Agents. ChemMedChem 2013, 8, 1537–1544. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Smith, A.B., III; Hirschmann, R.; Pasternak, A.; Yao, W.; Sprengeler, P.A.; Holloway, M.K.; Kuo, L.C.; Chen, Z.; Darke, P.L.; Schleif, W.A. An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease: Computational Analysis and X-ray Crystal Structure of the Enzyme Complex. J. Med. Chem. 1997, 40, 2440–2444. [Google Scholar] [CrossRef]
  66. Angermann, A.; Lehr, S.; Fischer, R.; Bojack, G.; Helmke, H.; Schmutzler, D.; Dietrich, H.; Gatzweiler, E.; Rosinger, C.H. New alkynyl-substituted 3-phenylpyrrolidine-2,4-diones and Use Thereof as Herbicides. WO 2017060203 A1, 13 April 2017. [Google Scholar]
  67. Grošelj, U.; Žorž, M.; Golobič, A.; Stanovnik, B.; Svete, J. α-Amino acid derived enaminones and their application in the synthesis of N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates and other heterocycles. Tetrahedron 2013, 69, 11092–11108. [Google Scholar] [CrossRef]
  68. Ričko, S.; Meden, A.; Ciber, L.; Štefane, B.; Požgan, F.; Svete, J.; Grošelj, U. Construction of Vicinal Tetrasubstituted Stereogenic Centers via a Mannich-Type Organocatalyzed Addition of Δ2-Pyrrolin-4-ones to Isatin Imines. Adv. Synth. Catal. 2018, 360, 1072–1076. [Google Scholar] [CrossRef]
  69. Ričko, S.; Meden, A.; Ivančič, A.; Perdih, A.; Štefane, B.; Svete, J.; Grošelj, U. Organocatalyzed Deracemization of Δ2-Pyrrolin-4-ones. Adv. Synth. Catal. 2017, 359, 2288–2296. [Google Scholar] [CrossRef]
  70. Ričko, S.; Svete, J.; Štefane, B.; Perdih, A.; Golobič, A.; Meden, A.; Grošelj, U. 1,3-Diamine-Derived Bifunctional Organocatalyst Prepared from Camphor. Adv. Synth. Catal. 2016, 358, 3786–3796. [Google Scholar]
  71. Grošelj, U.; Ciber, L.; Gnidovec, J.; Testen, Ž.; Požgan, F.; Štefane, B.; Tavčar, G.; Svete, J.; Ričko, S. Synthesis of Spiro-Δ2-Pyrrolin-4-One Pseudo Enantiomers via an Organocatalyzed Sulfa-Michael/Aldol Domino Sequence. Adv. Synth. Catal. 2019, 361, 5118–5126. [Google Scholar] [CrossRef]
  72. Grayson, M.N. Mechanism and Origins of Stereoselectivity in the Cinchona Thiourea- and Squaramide-Catalyzed Asymmetric Michael Addition of Nitroalkanes to Enones. J. Org. Chem. 2017, 82, 4396–4401. [Google Scholar] [CrossRef]
  73. Ričko, S.; Izzo, J.A.; Jørgensen, K.A. Insights on the Pseudo-Enantiomeric Properties of Bifunctional Cinchona Alkaloid Squaramide-derived Organocatalyst. Chem. Eur. J. 2020. Accepted Author Manuscript. [Google Scholar] [CrossRef]
  74. Ričko, S.; Požgan, F.; Štefane, B.; Svete, J.; Golobič, A.; Grošelj, U. Stereodivergent Synthesis of Camphor-Derived Diamines and Their Application as Thiourea Organocatalysts. Molecules 2020, 25, 2978. [Google Scholar] [CrossRef]
  75. Mailhol, D.; Duque, M.d.M.S.; Raimondi, W.; Bonne, D.; Constantieux, T.; Coquerel, Y.; Rodriguez, J. Enantioselective Organocatalytic Michael Addition of Cyclobutanones to Nitroalkenes. Adv. Synth. Catal. 2012, 354, 3523–3532. [Google Scholar] [CrossRef]
  76. Konishi, H.; Lam, T.Y.; Malerich, J.P.; Rawal, V.H. Enantioselective α-Amination of 1,3-Dicarbonyl Compounds Using Squaramide Derivatives as Hydrogen Bonding Catalysts. Org. Lett. 2010, 12, 2028–2031. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Baran, R.; Veverková, E.; Škvorcová, A.; Šebesta, R. Enantioselective Michael addition of 1,3-dicarbonyl compounds to a nitroalkene catalyzed by chiral squaramides—A key step in the synthesis of pregabalin. Org. Biomol. Chem. 2013, 11, 7705–7711. [Google Scholar] [CrossRef] [PubMed]
  78. Yang, W.; Du, D.-M. Highly Enantioselective Michael Addition of Nitroalkanes to Chalcones Using Chiral Squaramides as Hydrogen Bonding Organocatalysts. Org. Lett. 2010, 12, 5450–5453. [Google Scholar] [CrossRef]
  79. Badiola, E.; Fiser, B.; Gómez-Bengoa, E.; Mielgo, A.; Olaizola, I.; Urruzuno, I.; García, J.M.; Odriozola, J.M.; Razkin, J.; Oiarbide, M.; et al. Enantioselective Construction of Tetrasubstituted Stereogenic Carbons through Brønsted Base Catalyzed Michael Reactions: α′-Hydroxy Enones as Key Enoate Equivalent. J. Am. Chem. Soc. 2014, 136, 17869–17881. [Google Scholar] [CrossRef]
  80. Zhao, B.-L.; Du, D.-M. Catalytic asymmetric conjugate addition of various α-mercaptoketones to α,β-unsaturated N-acylated oxazolidin-2-ones with bifunctional organocatalyst. RSC Adv. 2014, 4, 27346–27353. [Google Scholar] [CrossRef]
  81. Vakulya, B.; Varga, S.; Csámpai, A.; Soós, T. Highly Enantioselective Conjugate Addition of Nitromethane to Chalcones Using Bifunctional Cinchona Organocatalysts. Org. Lett. 2005, 7, 1967–1969. [Google Scholar] [CrossRef]
Figure 1. Selected biologically active compounds possessing a spirooxindole scaffold.
Figure 1. Selected biologically active compounds possessing a spirooxindole scaffold.
Catalysts 10 01211 g001
Scheme 1. Bis-spiroheterocyclic oxindoles containing oxazolone, thiazolidinone, pyrazolone, pyrimidinedione, and pyrrolone structural motifs.
Scheme 1. Bis-spiroheterocyclic oxindoles containing oxazolone, thiazolidinone, pyrazolone, pyrimidinedione, and pyrrolone structural motifs.
Catalysts 10 01211 sch001
Scheme 2. Evaluation of organocatalysts I-XII in a model reaction 1a + 2a3a.
Scheme 2. Evaluation of organocatalysts I-XII in a model reaction 1a + 2a3a.
Catalysts 10 01211 sch002
Figure 2. Selected 5-arylidene-2-methyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylates 1 and 3-isothiocyanato oxindoles 2; color red—novel reported pyrrolones 1.
Figure 2. Selected 5-arylidene-2-methyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylates 1 and 3-isothiocyanato oxindoles 2; color red—novel reported pyrrolones 1.
Catalysts 10 01211 g002
Scheme 3. Synthesized bis-spiroheterocycles 3.
Scheme 3. Synthesized bis-spiroheterocycles 3.
Catalysts 10 01211 sch003
Figure 3. Single crystal X-ray structure depicting product 3b. Thermal ellipsoids are shown at 50% probability.
Figure 3. Single crystal X-ray structure depicting product 3b. Thermal ellipsoids are shown at 50% probability.
Catalysts 10 01211 g003
Scheme 4. Follow-up methylation of compound 3a.
Scheme 4. Follow-up methylation of compound 3a.
Catalysts 10 01211 sch004
Scheme 5. Postulated transition state leading to the product 3a.
Scheme 5. Postulated transition state leading to the product 3a.
Catalysts 10 01211 sch005
Table 1. Evaluation of organocatalyst IXb in bis-spiroheterocyclization of 5-arylidene-Δ2-pyrrolin-4-one 1a with 3-isothiocyanatooxindole 2a. a
Table 1. Evaluation of organocatalyst IXb in bis-spiroheterocyclization of 5-arylidene-Δ2-pyrrolin-4-one 1a with 3-isothiocyanatooxindole 2a. a
Catalysts 10 01211 i001
SolventYield (%)dree (%)
1toluene6095:579
21,4-dioxane4693:783
3Et2O3580:2075
41,2-dimethoxyethane4995:578
5THF5594:682
6CH2Cl26193:76
7PhCF36793:787
8acetone4494:687
9t-butyl methyl ketone4195:587
10MeCN3079:2152
11MeOH3486:1436
a 5-Arylidene-Δ2-pyrrolin-4-one 1a (0.1 mmol), 3-isothiocyanato oxindole 2a (0.13 mmol), catalyst IXb (10 mol%), solvent (1 mL), 25 °C, 24 h; ee and dr determined by HPLC after flash column chromatography.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ričko, S.; Testen, Ž.; Ciber, L.; Požgan, F.; Štefane, B.; Brodnik, H.; Svete, J.; Grošelj, U. Double Spirocyclization of Arylidene-Δ2-Pyrrolin-4-Ones with 3-Isothiocyanato Oxindoles. Catalysts 2020, 10, 1211. https://0-doi-org.brum.beds.ac.uk/10.3390/catal10101211

AMA Style

Ričko S, Testen Ž, Ciber L, Požgan F, Štefane B, Brodnik H, Svete J, Grošelj U. Double Spirocyclization of Arylidene-Δ2-Pyrrolin-4-Ones with 3-Isothiocyanato Oxindoles. Catalysts. 2020; 10(10):1211. https://0-doi-org.brum.beds.ac.uk/10.3390/catal10101211

Chicago/Turabian Style

Ričko, Sebastijan, Žan Testen, Luka Ciber, Franc Požgan, Bogdan Štefane, Helena Brodnik, Jurij Svete, and Uroš Grošelj. 2020. "Double Spirocyclization of Arylidene-Δ2-Pyrrolin-4-Ones with 3-Isothiocyanato Oxindoles" Catalysts 10, no. 10: 1211. https://0-doi-org.brum.beds.ac.uk/10.3390/catal10101211

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop